240
Participants
Start Date
June 9, 2023
Primary Completion Date
August 1, 2024
Study Completion Date
December 7, 2024
Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), 20 ml (two ampoules of 10 ml each) once a day intravenously in a dilution of 200 ml of 0.9% sodium chloride solution at a rate 3-4 ml/min, for 15 days + Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic Acid), 2 tablets 2 times a day, for 25 days
Placebo
Placebo, 20 ml (two ampoules of 10 ml each) once a day intravenously in a dilution of 200 ml of 0.9% sodium chloride solution at a rate 3-4 ml / min, for 15 days + Placebo, 2 tablets 2 times a day, for 25 days
City General Hospital №2, Saint Petersburg
City Hospital №40 of the Kurortny District, Saint Petersburg
Saint-Petersburg I.I.Dzanelidze Research Institute of Emergency Medicine, Saint Petersburg
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY